 CAMBRIDGE, Mass.--BUSINESS WIRE--- AVRO--AVROBIO, Inc. Nasdaq:AVRO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced Azadeh Golipour, VP of Manufacturing Operations at AVROBIO, will present virtually at the Cowen 2021 Gene Therapy: CMC Regulatory Summit at 11:30 a.m. ET on Friday, Jan. 29, 2021. About AVROBIO Our vision is to bring personalized gene therapy to the world. We aim to prevent, halt or reverse disease t 